RVNC Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Revance Therapeutics to Crown Laboratories Aug 12, 2024 09:33AM
RVNC Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Revance Therapeutics to Crown Laboratories Aug 12, 2024 09:33AM
Revance to Participate in Upcoming Investor Conferences Feb 21, 2024 08:00AM
Revance to Participate in the 43rd Annual Cowen Healthcare Conference Feb 27, 2023 08:00AM
5 Stock Coverage Initiations of Interest Today Sep 22, 2022 05:36PM
View Older Stories

Sep 15, 2022 04:05PM Revance Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Sep 13, 2022 05:55AM Revance Therapeutics (RVNC) Prices Upsized 8M Share Offering at $25/sh
Sep 12, 2022 09:32PM Revance Announces Pricing of $200.0 Million Upsized Public Offering of Common Stock
Sep 12, 2022 04:01PM Revance Therapeutics (RVNC) to Offer $150M in Stock
Sep 12, 2022 04:01PM Revance Announces Proposed Public Offering of Common Stock
Sep 8, 2022 10:44AM Revance Therapeutic (RVNC) PT Raised to $65 at Cowen After Daxxify Approved
Mar 2, 2022 08:00AM Revance to Participate in the Cowen 42nd Annual Health Care Conference
Feb 24, 2021 04:05PM Revance to Participate in Upcoming Virtual Healthcare Conferences
Feb 25, 2020 04:05PM Revance to Participate in the Cowen 40th Annual Health Care Conference
Dec 4, 2019 09:19AM Pre-Open 12/04: (HQY) (CHK) (EXPE) Higher (RVNC) (IMMU) (ZS) Lower (more...)
Dec 4, 2019 07:42AM Revance Therapeutics (RVNC) Prices 6.5M Share Offering at $17/Sh
Dec 4, 2019 07:41AM Revance Announces Pricing of Public Offering of Common Stock
Dec 3, 2019 06:02PM After-Hours Movers 12/03: (HQY) (GPRO) (MA) Higher; (RVNC) (RLMD) (RAPT) Lower (more...)
Dec 3, 2019 04:03PM Revance Therapeutics (RVNC) to Offer Common Stock
Dec 3, 2019 04:01PM Revance Announces Proposed Public Offering of Common Stock
Mar 5, 2019 04:05PM Revance to Participate in Upcoming Investor Conferences
Jan 22, 2019 04:05PM Revance Announces Closing of Public Offering of Common Stock
Jan 17, 2019 06:56AM Revance Therapeutics (RVNC) Prices 5.88M Share Common Offering at $17/Sh
Jan 17, 2019 06:50AM Revance Announces Pricing of Public Offering of Common Stock
Jan 15, 2019 04:18PM Revance Therapeutics (RVNC) Announces Proposed Approx. $100M Common Share Offering
Jan 15, 2019 04:17PM Revance Announces Proposed Public Offering of Common Stock
Sep 14, 2018 11:07AM Cowen Expects Revance Therapeutics (RVNC) Weakness to Reverse, Reiterates $55 Price Target
Mar 6, 2018 04:05PM Revance to Participate in Upcoming Investor Conferences
Dec 11, 2017 04:05PM Revance Announces Closing of Public Offering of Common Stock
Dec 7, 2017 08:34AM Revance Therapeutics (RVNC) Prices 5.34M Offering of Common Stock at $31/Share
Dec 7, 2017 08:30AM Revance Announces Pricing of Public Offering of Common Stock
Dec 5, 2017 04:46PM Revance Therapeutics (RVNC) Plans $175 Million Public Offering of Common Stock
Dec 5, 2017 04:45PM Revance Announces Proposed Public Offering of Common Stock
Nov 16, 2017 09:46AM Revance Therapeutic (RVNC): A 24-Week Neurotoxin Would Be Disruptive, KOL Survey Suggests - Cowen
Feb 22, 2017 04:05PM Revance to Participate in Upcoming Investor Conferences
Feb 23, 2016 04:05PM Revance to Participate in Upcoming Investor Conferences
Dec 24, 2015 09:26AM Pre-Open Stock Movers 12/24: (PN) (GWPH) (SUNE) Higher; (RVNC) (CALM) (NSC) Lower (more...)
Nov 9, 2015 12:10PM Revance Therapeutics Announces Closing of Public Offering of Common Stock
Nov 4, 2015 07:08AM Revance Therapeutics (RVNC) Prices 3.25M Common Offering at $36/Share
Nov 4, 2015 12:20AM Revance Therapeutics Announces Pricing of Public Offering of Common Stock
Nov 2, 2015 06:25AM Revance Therapeutics (RVNC) Announces 3.25M Stock Offering
Nov 2, 2015 06:02AM Revance Therapeutics Announces Proposed Public Offering of Common Stock
Jul 28, 2015 04:03PM Fresh Off Generic Sale, Allergan (AGN) is Poised for Merger of Epic Proportions (AMGN) (ABBV)
Jun 16, 2014 04:07PM Revance Therapeutics (RVNC) to Offer 3M Shares
Mar 3, 2014 06:57AM Cowen Starts Revance Therapeutic (RVNC) at Outperform
Feb 6, 2014 12:32PM Revance Therapeutics (RVNC) IPO Opens Sharply Higher, Continues to Gain
Jan 2, 2014 07:42AM Revance Therapeutics, Inc. (RVNC) Files $86.25M IPO
View Older Stories